Effect of resveratrol on myocardial fibrosis in mice with chronic viral myocarditis

Chinese Journal of Contemporary Pediatrics

Volumn 11, Issue 4, 2009, Pages 291-295

  Wang, Zhou Ping ^a   Hua, Yi Min ^a   Zhang, Xing ^a   Wang, Yi Bin ^a   Shi, Xiao Qing ^a   Li, Ming Yan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Collagens I and III; Fibrosis; Mice; Resveratrol; Viral myocarditis

Indexed keywords

COLLAGEN; MYOCARDIAL COLLAGEN; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; PROCOLLAGEN TYPE 1 CARBOXY TERMINAL PROPEPTIDE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PROTEIN PRECURSOR; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC DISEASE; CONTROLLED STUDY; COXSACKIE VIRUS B3; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HEART FUNCTION; HEART MUSCLE FIBROSIS; HISTOCHEMISTRY; HYPERPLASIA; LOW DRUG DOSE; MOUSE; MYOFIBROBLAST; NONHUMAN; VIRUS MYOCARDITIS;

ANIMALS; CHRONIC DISEASE; COLLAGEN TYPE I; COLLAGEN TYPE II; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; FIBROSIS; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; MYOCARDIUM; PEPTIDE FRAGMENTS; PROCOLLAGEN; STILBENES;

EID: 65349195008     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chinese source.
2. Chinese source.
3. Chinese source.
4. Chinese source.
5. Chinese source.
6. Olson ER, Nauqle JE, Zhang X, Bomser JA, Meszaros JG. Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol [J]. Am J Physiol Heart Circ Pyhsiol, 2005, 288(3):1131-1138.
7. Yoshida Y, Shioi T, Izami T. Resveratrol ameliorates experimental autoimmune myocarditis[J]. Circ J, 2007, 71 (3):397-404.
8. Chinese source.
9. Doering CW, Jalil JE, Janicki JS, Pick R, Aghib S, Abrahams C, et al. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypenrophy [J]. Cardiovasc Res, 1988, 22(10): 686-695.
10. Yu R, Hebbar V, Kim DW, Mandlekar S, Pezzuto JM, Kong AN. Resveratrol inhibits phorhol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways[J]. Mol Pharmacol, 2001, 60(1):217-224.
11. El-Mowafy AM, White RE. Resveratrol inhibits MAPK activity and nuclear translcation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects [J]. FEBS Let, 1999, 451 (1):63-67.
12. Haider UG, Sorescu D, Griendling KK, Vollmar AM, Dirsch VM. Resveratrol suppresses angittensin II-induced Akt/Protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells [J]. Mol Pharmacol, 2002, 62 (4): 772-777.
13. Chinese source.
14. Chinese source.
15. Querejeta R, Varo N, Lopez B, Larman M, Artinano E, Iuan C, et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease [J]. Circulation, 2000, 101(14):1729-1735.
16. Querejeta R, Lopez B, Gonzalez A, Sanchez E, Larman M, Martinez Ubago JL, et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin:relation to myocardial fibrosis[J]. Circulation, 2004, 110(10): 1263-1268.
17. Nojgaard C, Johansen JS, Christensen E, Skovgaard LT, Price PA, Becker U, et al. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease[J]. J Hepatol, 2003, 39(2):179-186.